A tribute to Professor Linda Cardozo
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - December 7, 2023 Category: OBGYN Authors: Philip Toozs ‐Hobson Tags: Commentary Source Type: research
MBRRACE ‐UK update: Key messages from the UK and Ireland Confidential Enquiries into Maternal Death and Morbidity 2023
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - November 29, 2023 Category: OBGYN Authors: Allison Felker,
Marian Knight Tags: MBRRACE-UK update Source Type: research
Information sharing and communication in management of large for gestational age babies in non ‐diabetic mothers
Key content
There is no specific UK guideline on how to identify or manage large for gestational age (LGA) fetuses in non-diabetic mothers.
There is conflicting evidence with regard to the optimal mode and timing of delivery in such women and babies in order to minimise the possible risks.
Pre-delivery patient –clinician discussion on management and mode of delivery in LGA babies can be challenging due to the lack of conclusive evidence and guidance for both screening and interventions, but it is crucial in order to facilitate information sharing, counselling and collaborative decision making.
Decision -making tools ...
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Gurnaaz Kahlon,
Sophie Relph,
Wai Yoong Tags: Education Source Type: research
A focus on progestogens in hormone replacement therapy
Key content
Women receiving estrogen replacement require concomitant progestogen to prevent endometrial hyperplasia and carcinoma.
A variety of progestogens are used in hormone replacement therapy (HRT), with different advantages and disadvantages and routes of administration.
Progestogenic side effects may be mild but can be debilitating and lead to the discontinuation of HRT, so progestogens should be tailored to the individual woman.
Combined HRT containing estrogen and progestogens may be associated with a small increase in the absolute risk of breast cancer, which is not seen in women taking estrogen alone. Howeve...
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Srirupa Ghosh,
Rachel Imrie,
James Goadsby,
Michael Savvas Tags: Review Source Type: research
Extra corporeal membrane oxygenation (ECMO) in pregnant and postpartum women
Key points
Extra corporeal membrane oxygenation (ECMO) is an advanced life support technique used in cases of respiratory and cardiovascular failure when conventional intensive care supportive therapies have been exhausted.
ECMO has been used to support pregnant and postpartum women and people presenting with several cardiac and respiratory pathologies; it has gained wider recognition among the obstetric community owing to the COVID-19 pandemic.
It is important for clinicians to understand the difference between veno-venous and veno-arterial ECMO and the different purposes of these configurations.
It is important to co...
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Anna Richmond,
Farah Siddiqui,
Caroline Sampson,
Matthew Charlton Tags: Review Source Type: research
Issue Information
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Tags: Issue Information Source Type: research
Update
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Marian Knight Tags: Update Source Type: research
What's new in guidance: Faculty of Sexual and Reproductive Healthcare (FSRH) update
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Nicola Mullin Tags: What's new in guidance Source Type: research
CPD questions for volume 25 issue 4
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Tags: CPD Source Type: research
Editorial
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Wai Yoong Tags: Editorial Source Type: research
What I've learnt … with Prof James Drife
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Wai Yoong,
James Drife Tags: Editor ’s Note Source Type: research
Authors' reply
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Anna McDougall,
Amelie Morin,
Tatsiana Kuzmich,
Funlayo Odejinmi Tags: Letters to the editor Source Type: research
Re: Advanced abdominal pregnancy: challenges, update and review current management
(Source: The Obstetrician and Gynaecologist)
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Hiralal Konar Tags: Letters to the editor Source Type: research
Information sharing and communication in management of large for gestational age babies in non ‐diabetic mothers
Key content
There is no specific UK guideline on how to identify or manage large for gestational age (LGA) fetuses in non-diabetic mothers.
There is conflicting evidence with regard to the optimal mode and timing of delivery in such women and babies in order to minimise the possible risks.
Pre-delivery patient –clinician discussion on management and mode of delivery in LGA babies can be challenging due to the lack of conclusive evidence and guidance for both screening and interventions, but it is crucial in order to facilitate information sharing, counselling and collaborative decision making.
Decision -making tools ...
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Gurnaaz Kahlon,
Sophie Relph,
Wai Yoong Tags: Education Source Type: research
A focus on progestogens in hormone replacement therapy
Key content
Women receiving estrogen replacement require concomitant progestogen to prevent endometrial hyperplasia and carcinoma.
A variety of progestogens are used in hormone replacement therapy (HRT), with different advantages and disadvantages and routes of administration.
Progestogenic side effects may be mild but can be debilitating and lead to the discontinuation of HRT, so progestogens should be tailored to the individual woman.
Combined HRT containing estrogen and progestogens may be associated with a small increase in the absolute risk of breast cancer, which is not seen in women taking estrogen alone. Howeve...
Source: The Obstetrician and Gynaecologist - October 20, 2023 Category: OBGYN Authors: Srirupa Ghosh,
Rachel Imrie,
James Goadsby,
Michael Savvas Tags: Review Source Type: research
